Tom M. Ganten
- Molecular Biology top 10%
- Hepatology top 2%
- Immunology top 5%
- Epidemiology top 10%
- Oncology top 10%
- Co-authors
- Ronald KoschnyHenning WalczakWolfgang StremmelTobias L. HaasJaromir SykoraMartin R. SprickKerstin HerzerHenning Schulze‐Bergkamen
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (19 papers)Cell death mechanisms and regulation (12 papers)Liver Disease and Transplantation (11 papers)
- Cited by
- HepatologyImmunologyTransplantation
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Tom M. Ganten
67 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 95
- Molecular Biology 1.1k
- Hepatology 471
- Immunology 467
- Epidemiology 452
- Oncology 414
Countries citing papers authored by Tom M. Ganten
This map shows the geographic impact of Tom M. Ganten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom M. Ganten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom M. Ganten more than expected).
Fields of papers citing papers by Tom M. Ganten
This network shows the impact of papers produced by Tom M. Ganten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom M. Ganten. The network helps show where Tom M. Ganten may publish in the future.
Co-authorship network of co-authors of Tom M. Ganten
This figure shows the co-authorship network connecting the top 25 collaborators of Tom M. Ganten. A scholar is included among the top collaborators of Tom M. Ganten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom M. Ganten. Tom M. Ganten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 12 | |
| 3 | 8 | |
| 4 | 3 | |
| 5 | 66 | |
| 6 | 1 | |
| 7 | 22 | |
| 8 | 43 | |
| 9 | LIVER TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS : AN ANALYSIS OF MEDICAL AND SURGICAL RISK FACTORS | 2 |
| 10 | 17 | |
| 11 | 69 | |
| 12 | 83 | |
| 13 | 2 | |
| 14 | 8 | |
| 15 | 102 | |
| 16 | 17 | |
| 17 | 7 | |
| 18 | 6 | |
| 19 | 142 | |
| 20 | 87 |
About Tom M. Ganten
Tom M. Ganten is a scholar working on Hepatology, Transplantation and Cancer Research, having authored 68 papers that have together received 2.0k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Cell death mechanisms and regulation (12 papers) and Liver Disease and Transplantation (11 papers). The work is most often cited by research in Hepatology (471 citations), Immunology (467 citations) and Transplantation (58 citations). Tom M. Ganten has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Ronald Koschny, Henning Walczak, Wolfgang Stremmel, Tobias L. Haas, Jaromir Sykora, Martin R. Sprick, Kerstin Herzer, Henning Schulze‐Bergkamen, Min Li‐Weber and Peter Büchler. Their work appears in journals such as Journal of Clinical Oncology, Hepatology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.